Sharemaestro company-news research for Nutriband Inc (NTRB), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Provisional evidence
Company news sentiment
Latest NTRB news and sentiment
Nutriband Inc
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score50Neutral is 50
Early balanced news score
21/100 evidence confidence
100% direct company focus
10 current stories across 7 publishers
Current company news
Early balanced news score
10 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone48/100
→
Published 30-day score50/100
Latest source headline
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
GlobeNewswire · 09 Sep 2026 13:20
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
10 current stories are mapped specifically to NTRB.
The score uses 7 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.175.
Confidence is 21/100, below the threshold for a firm score.
50/100
News scoreEarly balanced news score
21/100
Confidencethin evidence
100%/100
Company news10 company stories
82/100
Story agreement18/100 difference
News history
Daily score and story count over 30 days
25 Aug09 Sep23 Sep
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence3
0.175 after freshness weightingSource breadth100
7 independent publishersCompany relevance100
share tied directly to this companyFreshness6
recency-weighted evidenceAgreement82
how closely stories agreePublisher mix77
less reliance on one publisherPrice and news history
Weekly price and news-score history
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
26 completed price weeks17 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
27 Mar23 Jun18 Sep
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
18 Sep 202650USD 8.13+16.8%
11 Sep 202649USD 6.96+16.6%
04 Sep 202649USD 5.97+33.9%
28 Aug 202652USD 4.46-4.4%
21 Aug 202652USD 4.6664+41.4%
14 Aug 202653USD 3.3+6.1%
07 Aug 202651USD 3.11+9.1%
31 Jul 202652USD 2.85-4.4%
Provisional evidence
News subjects
What is shaping the score
Earnings495 stories · 50%
Market update503 stories · 30%
Balance sheet661 stories · 10%
Guidance381 stories · 10%
Source mix
Where the evidence comes from
GlobeNewswire502 stories · 20%
scanx.trade181 stories · 10%
dars.gov.et751 stories · 10%
CarePlus VietNam721 stories · 10%
Stock Titan661 stories · 10%
Stock Traders Daily381 stories · 10%
Kalkine Media601 stories · 10%
Recurring subjects
Subjects appearing most often
Life Sciences4Financial Markets2Finance2Earnings1
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
23 May50 neutral20 Sep 14:21
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 20 Sep 14:21 | 50 | +1 | 21/100 (-14) | 10 (-5) | Provisional |
| 09 Sep 23:59 | 49 | +0 | 35/100 (-2) | 15 (+1) | Provisional |
| 08 Sep 23:59 | 49 | +0 | 37/100 (-1) | 14 (+1) | Provisional |
| 04 Sep 23:59 | 49 | -4 | 38/100 (+9) | 13 (-2) | Provisional |
| 27 Aug 23:59 | 53 | -1 | 29/100 (+1) | 15 (-1) | Provisional |
| 25 Aug 23:59 | 54 | -1 | 28/100 (-2) | 16 (+1) | Provisional |
| 24 Aug 23:59 | 55 | +3 | 30/100 (+4) | 15 (-3) | Provisional |
| 21 Aug 23:59 | 52 | +0 | 26/100 (+2) | 18 (0) | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#1—Not directional
GlobeNewswireDirect company coverageScored from headline
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
Nutriband Inc. announced that its CEO, Gareth Sheridan, will attend the inaugural Nasdaq LaB Biotech Summit on September 16th. The summit aims to bring together biotechnology executives, investors, and industry leaders for thought leadership and networking. Nutriband is focused on developing transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating its AVERSA™ technology.
FinanceLife Sciences
- Published
- 09 Sep 2026 13:20
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 12.8d old
- Duplicates
- 1 consolidated
#2—Not directional
GlobeNewswireDirect company coverageScored from headline
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
Nutriband Inc. has announced it received a Notice of Publication from the USPTO for commercial brand name trademarks for its abuse-deterrent fentanyl transdermal system. Once allowed, the company plans to submit the brand name to the FDA and international regulatory agencies for approval. This system, based on Nutriband's AVERSA™ technology, aims to be the first abuse-deterrent fentanyl patch and has an estimated peak annual U.S. sales potential of $80 million to $200 million.
Life Sciences
- Published
- 08 Sep 2026 13:00
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 13.8d old
- Duplicates
- 1 consolidated
#360Tone
Kalkine MediaDirect company coverageStored article
NutriBand (NASDAQ: NTRB) Posts $437,514 Revenue Amid Declining Customer Demand
NutriBand (NASDAQ: NTRB) reported a significant decrease in quarterly revenue to $437,514 from $622,452, primarily due to a key customer relocating operations to Asia. Despite this, the company narrowed its net loss considerably to $880,561 from over $23 million previously. Gross profit improved due to reduced costs, but further demand softness is anticipated.
EarningsLife Sciences
- Published
- 08 Sep 2026 07:29
- News subject
- Earnings
- Why this score
- Loss narrowed, Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 41/100
- 30-day weight
- 16% of the score · 14.1d old
- Duplicates
- 1 consolidated
#438Tone
Stock Traders DailyDirect company coverageStored article
(NTRB) Movement Within Algorithmic Entry Frameworks
This article provides an algorithmic analysis of Nutriband Inc. (NASDAQ: NTRB), highlighting strong near and mid-term sentiment but a weak long-term outlook. It details specific institutional trading strategies including long, breakout, and short positions with defined entry zones, targets, and stop losses. The analysis also presents multi-timeframe signal strengths, support, and resistance levels for various time horizons.
FinanceFinancial Markets
- Published
- 08 Sep 2026 07:04
- News subject
- Guidance
- Why this score
- Weak guidance, Short Position
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 46/100
- 30-day weight
- 36.5% of the score · 14.1d old
- Duplicates
- 1 consolidated
#518Tone
scanx.tradeDirect company coverageScored from headline
Nutriband Q2 Results: EPS loss narrows to $(0.07), sales fall 29%
- Published
- 04 Sep 2026 22:12
- News subject
- Earnings
- Why this score
- Large negative market reaction, Operating deterioration
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- High · 62/100
- 30-day weight
- 14.6% of the score · 17.5d old
- Duplicates
- 1 consolidated
#666Tone
Stock TitanDirect company coverageScored from headline
NutriBand (NTRB) cuts cash burn as sales slip
- Published
- 04 Sep 2026 20:31
- News subject
- Balance sheet
- Why this score
- Cash generation improved
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 47/100
- 30-day weight
- 19.5% of the score · 17.5d old
- Duplicates
- 1 consolidated
#772Tone
CarePlus VietNamDirect company coverageScored from headline
NTRB Q2 2026 Earnings: Loss Narrows to $0.08 Per Share, a 95.85% Positive Surprise Over Consensus - Energy Earnings Report
- Published
- 04 Sep 2026 07:00
- News subject
- Earnings
- Why this score
- Loss narrowed
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 50/100
- 30-day weight
- 9.4% of the score · 18.1d old
- Duplicates
- 1 consolidated
#843Tone
Value ResearchDirect company coverageScored from headline
Nutriband Inc (NTRB) Financials – Balance Sheet, Profit & Loss, Cash Flow
- Published
- 27 Aug 2026 14:36
- News subject
- Earnings
- Why this score
- Negative financial language
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Low · 31/100
- 30-day weight
- 1.8% of the score · 25.8d old
- Duplicates
- 1 consolidated
#9—Not directional
MoomooDirect company coverageStored article
Nutriband (NTRB) Stock Forum and Discussion
This article provides a forum and discussion platform for Nutriband (NTRB) stock. It serves as a space for investors and interested parties to exchange information and opinions regarding the company's stock performance and related news.
Financial MarketsLife Sciences
- Published
- 25 Aug 2026 11:11
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 27.9d old
- Duplicates
- 1 consolidated
#1075Tone
dars.gov.etDirect company coverageScored from headline
Nutriband (NTRB) Financial Update: Profit Per Share Surpasses Its Benchmark; Stock Move: Shares Move Higher 22.31% - Profit Margin Analysis
- Published
- 24 Aug 2026 07:00
- News subject
- Earnings
- Why this score
- Beat expectations
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 51/100
- 30-day weight
- 2.2% of the score · 29.1d old
- Duplicates
- 1 consolidated
Earlier company news
NTRB news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 40 older NTRB headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to NTRB, but the headline and available text are not mainly about Nutriband Inc. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of NTRB sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.